These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25847811)
1. How can follow-up of patients with Raynaud phenomenon be optimized? Kadan M; Erol G; Karabacak K; Kaya E; Arslan G; Doğancı S; Demirkılıç U Med Sci Monit Basic Res; 2015 Apr; 21():47-52. PubMed ID: 25847811 [TBL] [Abstract][Full Text] [Related]
2. Platelet indices may be correlated with severity of vasospastic disorders. Kadan M; Karabacak K; Kaya E; Arslan G; Erol G; Doğancı S; Yıldırım V; Bolcal C; Demirkılıç U Med Sci Monit Basic Res; 2015 Apr; 21():63-7. PubMed ID: 25872023 [TBL] [Abstract][Full Text] [Related]
3. Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal difference in the thermographic assessment of Raynaud's phenomenon. Pauling JD; Flower V; Shipley JA; Harris ND; McHugh NJ Microvasc Res; 2011 Nov; 82(3):364-8. PubMed ID: 21420982 [TBL] [Abstract][Full Text] [Related]
4. Adding Doppler ultrasonography to the follow-up of patients with vasospastic disorder improves objectivity. Karabacak K; Kadan M; Kaya E; Erol G; Arslan G; Celik M; Doğanci S; Demirkilic U Med Sci Monit Basic Res; 2015 Feb; 21():4-8. PubMed ID: 25639947 [TBL] [Abstract][Full Text] [Related]
5. A cold-response index for the assessment of Raynaud's phenomenon. Foerster J; Kuerth A; Niederstrasser E; Krautwald E; Pauli R; Paulat R; Eweleit M; Riemekasten G; Worm M J Dermatol Sci; 2007 Feb; 45(2):113-20. PubMed ID: 17169532 [TBL] [Abstract][Full Text] [Related]
6. Analysis of rewarming curves in Raynaud's phenomenon of various aetiologies. Salem KM; Baker M; Hilliam RM; Davies S; Deighton C; Bainbridge LC; Manning G J Hand Surg Eur Vol; 2009 Oct; 34(5):621-6. PubMed ID: 19687085 [TBL] [Abstract][Full Text] [Related]
7. Three-grade classification of photoplethysmography for evaluating the effects of treatment in Raynaud phenomenon. Yang SS; Park KM; Kim YW; Kim DI Angiology; 2013 Nov; 64(8):609-13. PubMed ID: 23052723 [TBL] [Abstract][Full Text] [Related]
8. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis. Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495 [TBL] [Abstract][Full Text] [Related]
9. Follow-Up of Treatment Response With Dynamic Doppler Ultrasound in Raynaud Phenomenon. Toprak U; Ozbalkan Z; Erdugan M; Parlak S; Sandıkcı SC; Kaya T; Şaylısoy S AJR Am J Roentgenol; 2017 Dec; 209(6):W388-W394. PubMed ID: 28981361 [TBL] [Abstract][Full Text] [Related]
10. Infrared thermography in the diagnosis of Raynaud's phenomenon in vibration-induced white finger. von Bierbrauer A; Schilk I; Lucke C; Schmidt JA Vasa; 1998 May; 27(2):94-9. PubMed ID: 9612113 [TBL] [Abstract][Full Text] [Related]
11. Low level laser therapy in primary Raynaud's phenomenon--results of a placebo controlled, double blind intervention study. Hirschl M; Katzenschlager R; Francesconi C; Kundi M J Rheumatol; 2004 Dec; 31(12):2408-12. PubMed ID: 15570642 [TBL] [Abstract][Full Text] [Related]
12. Raynaud phenomenon of the nipple: a rare finding in rheumatology clinic. O'Sullivan S; Keith MP J Clin Rheumatol; 2011 Oct; 17(7):371-2. PubMed ID: 21946463 [TBL] [Abstract][Full Text] [Related]
13. Determination of fingertip lacticemy before and after cold stimulus in patients with primary Raynaud's phenomenon and systemic sclerosis. Pucinelli ML; Fontenelle S; Andrade LE J Rheumatol; 2002 Jul; 29(7):1401-3. PubMed ID: 12136896 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients. Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637 [TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease. Caglayan E; Huntgeburth M; Karasch T; Weihrauch J; Hunzelmann N; Krieg T; Erdmann E; Rosenkranz S Arch Intern Med; 2006 Jan; 166(2):231-3. PubMed ID: 16432094 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Raynaud phenomenon in systemic sclerosis. Sinnathurai P; Schrieber L Intern Med J; 2013 May; 43(5):476-83. PubMed ID: 23347192 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Murray AK; Moore TL; Manning JB; Taylor C; Griffiths CE; Herrick AL Arthritis Rheum; 2009 Aug; 61(8):1103-11. PubMed ID: 19644893 [TBL] [Abstract][Full Text] [Related]
19. The assessment of Raynaud's phenomenon using a radiation thermometer and a mild cold (20 degrees C) stress test. Bull ML; Evans MJ; Gupta R; Grigg MJ; Nicolaides AN Int Angiol; 1986; 5(4):237-42. PubMed ID: 3585096 [TBL] [Abstract][Full Text] [Related]
20. [The usefulness of capillaroscopy for the evaluation of pulsed magnetic field therapy in patients with primary and secondary Raynaud's phenomenon]. Kuryliszyn-Moskal A; Kita J; Dakowicz A; Klimiuk PA Ann Acad Med Stetin; 2011; 57(3):17-22; discussion 22. PubMed ID: 23383543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]